High Cholesterol

31 registered clinical trials studyying High Cholesterol — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Cobas® Lumira Collection of Venous and Capillary Blood Samples for the Research, Optimization and Calibration NCT07378514	LumiraDx UK Limited	—
Recruiting	Phase 1a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RN5681 in Healt NCT07347678	Ikaria Bioscience Pty Ltd	Phase 1
Recruiting	FELLAShip to Better Health NCT07220213	University of Alabama at Birmingham	N/A
Recruiting	Healthy Living Anson Study NCT07126587	University of North Carolina, Chapel Hill	N/A
Active Not Recruiting	Effect of Herring Oil Concentrate on LDL Cholesterol Concentration in Adults NCT06364163	University of Bergen	N/A
Completed	The Benefits of the Measureof Epicardial Adipose Tissue During Coronary Calcium Assessment of the Refine Cardi NCT07090629	Centre Hospitalier Universitaire de la Réunion	—
Completed	Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies NCT06005597	NewAmsterdam Pharma	Phase 3
Completed	Project WHADE: A Partner-Based Physical Activity Program for Women NCT06350604	Rowan University	N/A
Recruiting	Complete Lifestyle Medicine Intervention Program NCT06192251	Northern Ontario School of Medicine	—
Completed	BVA-200 vs BVA-100 Validation Study NCT06227819	Daxor Corporation	—
Unknown	Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY) NCT05473325	Willows Health	—
Completed	Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies NCT05425745	NewAmsterdam Pharma	Phase 3
Completed	A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin NCT05421078	NewAmsterdam Pharma	Phase 2
Completed	Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy NCT05266586	NewAmsterdam Pharma	Phase 2
Completed	Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies NCT05142722	NewAmsterdam Pharma	Phase 3
Completed	Technology-Assisted Cholesterol Trial in Consumers (TACTiC) NCT04964544	AstraZeneca	Phase 3
Withdrawn	Evolocumab In Advanced Chronic Kidney Disease Trial NCT04510844	NYU Langone Health	Phase 4
Completed	Randomized Study of Obicetrapib in Combination With Ezetimibe NCT04770389	NewAmsterdam Pharma	Phase 2
Completed	Randomized Study of Obicetrapib as an Adjunct to Statin Therapy NCT04753606	NewAmsterdam Pharma	Phase 2
Completed	Online Trial Examining Validity and Reliability of the Shared Decision Making Process Survey NCT04317690	Massachusetts General Hospital	—
Completed	Online Trial Examining Validity of the Shared Decision Making Process Survey With Video Vignettes NCT04317274	Massachusetts General Hospital	N/A
Completed	Creating Healthier Communities Through Meaningful Partnerships: A Model From the National African American Mal NCT04787978	Ohio State University	N/A
Terminated	Arts & Health Education to Improve Health, Resilience, and Well-Being NCT04154579	Lisa Gallagher	N/A
Completed	Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome NCT03542240	Virginia Commonwealth University	N/A
Completed	Habitual Diet and Avocado Trial NCT03528031	Wake Forest University Health Sciences	N/A
Completed	Cardiovascular Health Promotion Among African-Americans by FAITH! NCT03084822	Mayo Clinic	N/A
Completed	Additive Effects of Pravastatin and Valsartan NCT01004237	Gachon University Gil Medical Center	Phase 4
Terminated	Ezetimibe in Patients Hypo-responsive to Statins NCT00965055	University of California, San Diego	Phase 3
Terminated	The Effect of Atorvastatin on Endothelial Cell Dysfunction in Chronic Kidney Disease NCT02133534	Duke University	Phase 4
Completed	The RISAP-study: a Complex Intervention in Risk Communication and Shared Decision-making in General Practice NCT01187056	University of Aarhus	N/A
Completed	Effect of Policosanol as Monotherapy and Adjunctive to Statin Therapy NCT00510809	James Backes, PharmD	N/A